Hemodynamic Monitoring Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Product (Disposable v/s Monitors), By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems), By End User (Hospitals, Clinics, and Ambulatory Care Centres), By Region, and Competition Pages

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

The Global Hemodynamic Monitoring System Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing developments in hemodynamic monitoring systems, and growth enhancement in the research of hemodynamic monitoring systems across the globe. Additionally, the increasing prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, and vascular diseases, and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about hemodynamic monitoring systems and procedural benefits provided by monitoring systems for the treatment of cardiovascular diseases is further boosting the market growth during the forecast period. Cardiovascular disease (CVD), listed as the underlying cause of death, accounted for 874,613 deaths in the United States in 2019. Hemodynamic monitoring systems are often expensive, which can make them difficult to afford for some healthcare providers, particularly in low- and middle-income countries. This can limit the adoption of these devices, particularly in resource-limited settings. The lack of adequate reimbursement policies can limit the adoption of hemodynamic monitoring systems, particularly in healthcare systems where costs are borne by patients or healthcare providers. The development and approval of hemodynamic monitoring systems can be a lengthy and costly process due to regulatory hurdles, such as obtaining regulatory approval from the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Alternative technologies, such as non-invasive monitoring devices and wearable sensors, may compete with hemodynamic monitoring systems. These devices may be more convenient and less invasive, making them more attractive to some healthcare providers and patients. The PULSION Medical Systems PiCCOsmarT system is a hemodynamic monitoring platform that provides real-time data on cardiac output, stroke volume, and other key parameters using a minimally invasive catheter system. The system includes advanced algorithms to provide accurate and reliable data and can be used in a variety of clinical settings, including intensive care units and operating rooms.

Technological advancements

According to recent research, it has been observed that the increasing demand for non-invasive technologies is rapidly growing over conventionally accepted invasive technology in present years. These monitoring systems help to diagnose pain and reduce the risk of blood-borne infections in patients. Similarly, these systems are easy to use and can be operated by a nurse without the supervision of a doctor or any specialist. Due to its advantages, these systems can be simultaneously monitored in different patients which lower the cost of staff and treatment expenditure. Additionally, the growing usage of hemodynamic monitoring for CVP, hemodynamic monitoring non-invasive systems, hemodynamic monitoring invasive systems, hemodynamic monitoring during CPB, hemodynamic monitoring transducers, hemodynamic monitoring transducers, hemodynamic monitoring cardiogenic shocks, hemodynamic monitoring echocardiography, hemodynamic monitoring flotrac , hemodynamic monitoring in heart failure, haemorrhage, arterial line, etc are expected to create a lucrative growth during the forecast period. Similarly, the expansion of the hemodynamic monitoring systems market and devices market are boosting the market growth rate during the forecast period. In March 2021, Philips introduced its interventional hemodynamic system featuring a patient monitor- IntelliVue X3 to provide advanced hemodynamic (blood flow) measurements and improve patient focus during image-guided procedures. The development of new and advanced hemodynamic monitoring systems, such as minimally invasive devices and wireless monitoring systems, is driving the growth of the market. These devices offer greater accuracy, convenience, and reduced risk of infection, making them more attractive to healthcare providers. Several government initiatives aimed at improving healthcare infrastructure and promoting the adoption of advanced medical technologies are expected to drive the growth of the hemodynamic monitoring system market. For example, the Affordable Care Act in the US includes provisions that encourage the adoption of innovative medical devices and technologies. Advances in data analytics and visualization have led to the development of hemodynamic monitoring systems that provide real-time data visualization and analysis, allowing healthcare providers to quickly identify trends and make informed clinical decisions. There has been an increased focus on patient safety in hemodynamic monitoring, with efforts to reduce the risk of infection associated with invasive monitoring procedures, such as the use of antimicrobial-coated catheters. The Cheetah Medical Starling SV system is a non-invasive hemodynamic monitoring platform that uses bioimpedance technology to provide real-time data on stroke volume, cardiac output, and other key hemodynamic parameters. The system includes a lightweight sensor that is placed on the patient's chest and does not require any invasive procedures.

Growing Prevalence of Cardiovascular Diseases

Advanced hemodynamic monitoring methods can enhance the monitoring systems of cardiac patients during post-operative care and anaesthesia - repetitive measurements for the detection of hemodynamic abnormalities and their causes. Cardiovascular diseases are one of the major chronic diseases across the world. Coronary heart syndrome, cerebrovascular diseases, rheumatic heart diseases, and other illnesses are among them blood vessel disorders known as CVDs. According to WHO, 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year. Furthermore, the increasing burden of CVDs triggers the increased adoption of hemodynamic monitoring systems during the forecast period. 96 million people aged 18 years or older have prediabetes in the United States and Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. The rising incidence of cardiovascular diseases, such as heart failure, hypertension, and coronary artery disease, is one of the primary drivers of the hemodynamic monitoring system market. These conditions often require constant monitoring of hemodynamic parameters to ensure adequate blood flow and oxygen delivery to vital organs. The aging population is another significant driver of the hemodynamic monitoring system market. Older adults are more susceptible to cardiovascular diseases and are more likely to require hemodynamic monitoring during surgical procedures and in the ICU. The growing trend towards minimally invasive procedures is driving the demand for hemodynamic monitoring systems that can provide accurate data without invasive procedures. These procedures are often performed in ambulatory surgical centers, which are expected to be a significant growth area for the hemodynamic monitoring system market. Exposure to air pollution, particularly fine particulate matter (PM2.5), has been linked to an increased risk of CVD. Air pollution can contribute to the development of hypertension, atherosclerosis, and myocardial infarction. Family history of CVD is a significant risk factor for the development of the disease. Some genetic factors increase the risk of CVD, such as familial hypercholesterolemia, which is an inherited condition that causes high levels of cholesterol in the blood. Urbanization is associated with increased levels of physical inactivity, stress, and unhealthy dietary habits, which can contribute to the development of CVD. The Edwards Lifesciences HemoSphere system is a comprehensive hemodynamic monitoring platform that provides real-time data on key hemodynamic parameters, including cardiac output, stroke volume, and systemic vascular resistance. The system uses advanced algorithms to provide accurate and reliable data, and includes a variety of catheter options to meet the needs of different patient populations.

Recent Development

  • One such minimally/non-invasive Hemodynamic Monitor is made by renowned UK-based manufacturer LiDCO, the LiDCOrapid, with minimally invasive monitoring via the standard radial arterial line and one cost-effective disposable.
  • In February 2022, Caretaker Medical received the US Food and Drug Administration (FDA) clearance to add four new parameters on its next-generation VitalStream wireless ‘beat-by-beat’ blood pressure and hemodynamic monitoring platform, to include stroke volume, cardiac output, left ventricular ejection time, and heart rate variability.
  • In July 2022, Retia Medical received Series B funding of $15 million led by Fresenius Medical Care Ventures to expand its commercial team and accelerate the development and commercialization of its Argos Hemodynamic Monitor.
  • In 2020, Philips, a leading provider of healthcare technology, acquired Xhale Assurance, a company specializing in non-invasive monitoring technologies. The acquisition expanded Philips' portfolio of monitoring systems and provided access to new technologies for non-invasive monitoring of key hemodynamic parameters.\
  • In 2020, ICU Medical, a leading provider of infusion therapy and critical care products, acquired the hemodynamic monitoring product line of Cheetah Medical, a company specializing in non-invasive monitoring technologies. The acquisition expanded ICU Medical's portfolio of monitoring systems and provided access to new technologies for non-invasive monitoring of key hemodynamic parameters.
  • In 2019, Baxter International, a leading provider of renal and hospital products, acquired Cheetah Medical, a company specializing in non-invasive monitoring technologies. The acquisition expanded Baxter International's portfolio of monitoring systems and provided access to new technologies for non-invasive monitoring of key hemodynamic parameters.


Download Free Sample Report

Market Segmentation

The global hemodynamic monitoring system market can be segmented by product, type, end-user, and region. Based on the product, the market can be divided into Disposable and Monitors. Based on type, the market can be grouped into Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, and Non-invasive Hemodynamic Monitoring Systems. Based on end users, the market can be segmented into Hospitals, Clinics, and Ambulatory Care Centers. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global hemodynamic monitoring market on account of the growing demand for minimally invasive surgeries with low costs for the treatment of cardiovascular diseases.

Market Players

Edwards Lifesciences Corporation, Pulsion Medical Systems Se., Lidco Group Limited., Deltex Medical Group PLC., ICU Medical Inc., Cnsystems Medizintechnik GmbH., Caretaker Medical Inc., Osypka Medical GmbH., Cheetah Medical., NI Medical., Uscom. are some of the leading players operating in the Global Hemodynamic Monitoring System Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         By Product

·         By Type

·         By End User

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Edwards Lifesciences Corporation, Pulsion Medical Systems Se., Lidco Group Limited., Deltex Medical Group PLC., ICU Medical Inc., Cnsystems Medizintechnik GmbH., Caretaker Medical Inc., Osypka Medical GmbH., Cheetah Medical., NI Medical., Uscom

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, the global hemodynamic monitoring systems market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Hemodynamic Monitoring Systems Market, By Product:

o    Disposable

o    Monitors

  • Hemodynamic Monitoring Systems Market, By Type:

o    Invasive Hemodynamic Monitoring Systems

o    Minimally Invasive Hemodynamic Monitoring Systems

o    Non-invasive Hemodynamic Monitoring Systems

  • Hemodynamic Monitoring Systems Market, By End Users:

o    Hospitals

o    Clinics

o    Ambulatory Care Centers

  • Hemodynamic Monitoring Systems Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hemodynamic Monitoring Systems Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Hemodynamic Monitoring Systems Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Hemodynamic Monitoring Systems Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Disposable v/s Monitors)

5.2.2.     By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems)

5.2.3.     By End User (Hospitals, Clinics, and Ambulatory Care Centres)

5.2.4.     By Region

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1.     By Product

5.3.2.     By Type

5.3.3.     By End User

5.3.4.     By Region

6.    North America Hemodynamic Monitoring Systems Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Disposable v/s Monitors)

6.2.2.     By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems)

6.2.3.     By End User (Hospitals, Clinics, and Ambulatory Care Centres)

6.2.4.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Hemodynamic Monitoring Systems Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product

6.3.1.2.2.             By Type

6.3.1.2.3.             By End User

6.3.2.     Canada Hemodynamic Monitoring Systems Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product

6.3.2.2.2.             By Type

6.3.2.2.3.             By End User

6.3.3.     Mexico Hemodynamic Monitoring Systems Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product

6.3.3.2.2.             By Type

6.3.3.2.3.             By End User

7.    Europe Hemodynamic Monitoring Systems Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product (Disposable v/s Monitors)

7.2.2.     By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems)

7.2.3.     By End User (Hospitals, Clinics, and Ambulatory Care Centres)

7.2.4.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Hemodynamic Monitoring Systems Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Type

7.3.1.2.3.             By End User

7.3.2.     Germany Hemodynamic Monitoring Systems Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Type

7.3.2.2.3.             By End User

7.3.3.     United Kingdom Hemodynamic Monitoring Systems Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Type

7.3.3.2.3.             By End User

7.3.4.     Italy Hemodynamic Monitoring Systems Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Type

7.3.4.2.3.             By End User

7.3.5.     Spain Hemodynamic Monitoring Systems Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Type

7.3.5.2.3.             By End User

8.    Asia-Pacific Hemodynamic Monitoring Systems Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product (Disposable v/s Monitors)

8.2.2.     By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems)

8.2.3.     By End User (Hospitals, Clinics, and Ambulatory Care Centres)

8.2.4.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Hemodynamic Monitoring Systems Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Type

8.3.1.2.3.             By End User

8.3.2.     India Hemodynamic Monitoring Systems Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Type

8.3.2.2.3.             By End User

8.3.3.     Japan Hemodynamic Monitoring Systems Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Type

8.3.3.2.3.             By End User

8.3.4.     South Korea Hemodynamic Monitoring Systems Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Type

8.3.4.2.3.             By End User

8.3.5.     Australia Hemodynamic Monitoring Systems Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Type

8.3.5.2.3.             By End User

9.    South America Hemodynamic Monitoring Systems Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product (Disposable v/s Monitors)

9.2.2.     By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems)

9.2.3.     By End User (Hospitals, Clinics, and Ambulatory Care Centres)

9.2.4.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Hemodynamic Monitoring Systems Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Type

9.3.1.2.3.             By End User

9.3.2.     Argentina Hemodynamic Monitoring Systems Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Type

9.3.2.2.3.             By End User

9.3.3.     Colombia Hemodynamic Monitoring Systems Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Type

9.3.3.2.3.             By End User

10.  Middle East and Africa Hemodynamic Monitoring Systems Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product (Disposable v/s Monitors)

10.2.2.  By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems)

10.2.3.  By End User (Hospitals, Clinics, and Ambulatory Care Centres)

10.2.4.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Hemodynamic Monitoring Systems Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Type

10.3.1.2.3.           By End User

10.3.2.  Saudi Arabia Hemodynamic Monitoring Systems Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Type

10.3.2.2.3.           By End User

10.3.3.  UAE Hemodynamic Monitoring Systems Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Type

10.3.3.2.3.           By End User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Global Hemodynamic Monitoring Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Product Offerings

15.3.              Recent Developments

15.4.              Financials (As Reported)

15.5.              Key Personnel

15.6.              SWOT Analysis

15.6.1.  Edwards Lifesciences Corporation

15.6.2.  Pulsion Medical Systems Se.

15.6.3.  Lidco Group.

15.6.4.  Deltex Medical Group PLC.

15.6.5.  ICU Medical Inc.

15.6.6.  Cnsystems Medizintechnik GmbH.

15.6.7.  Caretaker Medical.

15.6.8.  Osypka Medical GmbH.

15.6.9.  Cheetah Medical.

15.6.10.                NI Medical.

15.6.11.                Uscom.

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing development in hemodynamic monitoring systems along with the growing prevalence of cardiovascular diseases and type-2 diabetes is some of the major factors driving the growth of the global hemodynamic monitoring systems market.

down-arrow

Edwards Lifesciences Corporation, Pulsion Medical Systems Se., Lidco Group Limited., Deltex Medical Group PLC., ICU Medical Inc., Cnsystems Medizintechnik GmbH., Caretaker Medical Inc., Osypka Medical GmbH., Cheetah Medical., NI Medical., Uscom are some of the leading players operating in the Global Hemodynamic Monitoring Systems Market.

down-arrow

Monitors are expected to dominate the global hemodynamic monitoring systems market during the forecast period.

down-arrow

North American region is expected to hold the largest share in the Global Hemodynamic Monitoring Systems Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Hemodynamic Monitoring Market to be dominated by Non-Invasive Hemodynamic Monitoring segment through 2028

Dec, 2022

The increasing prevalence of cardiac disorders is expected to drive Global Hemodynamic Monitoring Market in the forecast period, 2024-2028.

Why Choose Us